4D Molecular Therapeutics Will Host Investor Day October 21
The biotech firm will detail progress on its late-stage retinal and respiratory gene therapy programs.
New York City Biotech
Recent news
September 30, 2026
Sol-Gel Will Host Gorlin Syndrome Investor Event Oct 14The company will discuss the therapeutic potential and safety profile of SGT-610 in a presentation to investors.
September 24, 2026
Researchers Mapped Retinal Channel Binding SiteThe study offers a new target for drug development to treat retinal degeneration by stabilizing ion channel activity.
September 22, 2026
Evvy Raised $40 Million for Microbiome DiagnosticsThe New York-based company will use the funding to expand its metagenomic testing platform into fertility diagnostics.